Cubist Systematic Strategies LLC Makes New $586,000 Investment in U.S. Physical Therapy, Inc. (NYSE:USPH)

Cubist Systematic Strategies LLC acquired a new position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 6,610 shares of the company's stock, valued at approximately $586,000.

Several other large investors also recently added to or reduced their stakes in USPH. Bahl & Gaynor Inc. grew its stake in shares of U.S. Physical Therapy by 135.4% during the fourth quarter. Bahl & Gaynor Inc. now owns 260,125 shares of the company's stock valued at $23,076,000 after buying an additional 149,622 shares during the last quarter. Copeland Capital Management LLC grew its stake in shares of U.S. Physical Therapy by 9.5% during the fourth quarter. Copeland Capital Management LLC now owns 839,356 shares of the company's stock valued at $74,459,000 after buying an additional 72,715 shares during the last quarter. Raymond James Financial Inc. bought a new position in shares of U.S. Physical Therapy during the fourth quarter valued at approximately $6,240,000. Envestnet Asset Management Inc. grew its stake in shares of U.S. Physical Therapy by 20.1% during the fourth quarter. Envestnet Asset Management Inc. now owns 299,791 shares of the company's stock valued at $26,594,000 after buying an additional 50,163 shares during the last quarter. Finally, Proficio Capital Partners LLC bought a new position in shares of U.S. Physical Therapy during the fourth quarter valued at approximately $3,526,000.

Insiders Place Their Bets

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the company's stock in a transaction on Friday, March 7th. The stock was sold at an average price of $82.11, for a total transaction of $142,050.30. Following the completion of the sale, the chief operating officer now owns 7,168 shares in the company, valued at $588,564.48. This represents a 19.44% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 2.00% of the stock is owned by company insiders.

U.S. Physical Therapy Stock Up 1.3%

U.S. Physical Therapy stock opened at $78.23 on Friday. The business has a fifty day moving average of $71.84 and a two-hundred day moving average of $83.56. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. The firm has a market cap of $1.19 billion, a P/E ratio of 83.22, a P/E/G ratio of 3.54 and a beta of 1.44. U.S. Physical Therapy, Inc. has a twelve month low of $62.77 and a twelve month high of $107.72.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share for the quarter, topping analysts' consensus estimates of $0.46 by $0.02. The company had revenue of $183.79 million during the quarter, compared to analyst estimates of $176.78 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. U.S. Physical Therapy's revenue was up 18.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.51 earnings per share. On average, analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Friday, May 23rd will be issued a dividend of $0.45 per share. The ex-dividend date of this dividend is Friday, May 23rd. This represents a $1.80 dividend on an annualized basis and a yield of 2.30%. U.S. Physical Therapy's dividend payout ratio is currently 82.57%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the company. Barrington Research cut their target price on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a research note on Friday, February 28th. JPMorgan Chase & Co. lowered their price target on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Wednesday, March 19th. William Blair reiterated a "market perform" rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. JMP Securities reiterated a "market outperform" rating and issued a $113.00 price target on shares of U.S. Physical Therapy in a report on Tuesday, April 22nd. Finally, StockNews.com upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a report on Thursday, May 8th. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $109.00.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.